$230+ Bn Anti-Infectives Markets - Global Strategic Business Report to 2030: Telemedicine and Digital Health Platforms Drives Adoption, Rising Prevalence of Drug-Resistant Infections Spurs Innovation
July 22, 2024 09:15 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "Anti-Infectives - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Anti-Infectives...
$6.6 Bn Herpes Simplex Virus Infections Markets - Global Strategic Business Report to 2030 with Coverage of 10+ Major Players Including Admedus, Agenus, and Aicuris Anti-infective Cures
July 19, 2024 08:50 ET
|
Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "Herpes Simplex Virus Infections - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Chagas Disease Therapeutic Assessment 2024: Comprehensive Insights About 5+ Companies and 5+ Pipeline Drugs
July 17, 2024 10:10 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Chagas disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Cytomegalovirus Infection Therapeutics Research 2024: Comprehensive Insights About 15+ Companies and 20+ Pipeline Drugs Featuring Vir, SpyBiotech, Moderna, VBI, Trellis Bioscience, GSK, & AlloVir
July 03, 2024 04:10 ET
|
Research and Markets
Dublin, July 03, 2024 (GLOBE NEWSWIRE) -- The "Cytomegalovirus Infection - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Cytomegalovirus...
Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review 2024: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type
July 01, 2024 09:52 ET
|
Research and Markets
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Ceftriaxone Industry Research 2024: Effective Treatment of Multi-Drug Resistant Infections Bolsters Growth - Global Forecasts to 2032
June 28, 2024 11:31 ET
|
Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Global Ceftriaxone Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts,...
Innovative Progress in BK Virus (BKV) Infection Pipeline: 2024 Drug Insights - Therapeutic Assessment and Opportunities
June 18, 2024 10:11 ET
|
Research and Markets
Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "BK Virus (BKV) Infection - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The medical community hails the...
Chlamydia Pipeline Landscape Research 2024: Therapeutic Assessment of 5+ Companies and 5+ Pipeline Drugs by Type, Stage, Route of Administration, and Molecule
June 17, 2024 07:26 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Chlamydia - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "Chlamydia- Pipeline Insight, 2024" report...
Analysis of the Global Sepsis Pipeline, 2024 with Insights on 30+ Companies and 35+ Pipeline Drugs, Including Thymosin Alpha 1 (Sci Clone Pharmaceuticals) and Enibarcimab (AdrenoMed)
May 31, 2024 06:18 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
Shingles Treatment Pipeline Report 2024: Key Products, Companies, Unmet Needs, Emerging Therapies, Challenges and Opportunities
May 28, 2024 07:13 ET
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Shingles - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.This report offers comprehensive and strategic insights...